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The amounts of tissue factor (TF) expressed by brain microvascular endothelial cells (BMECs) from normotensive Wistar-Kyoto rats (WKY) and 
spontaneously hypertensive rats (SHR) were compared after stimulating the cells with different doses of lipopolysaccharide (LPS), thrombin, 
phorbol myristic acid (PMA), Ca2+·ionophore (A23187), or tumor necrosis factor (TNF) and interleukin·l (IL.l). Treatment ofcultured BMECs 
fron. WKY and SHR with all of these factors dose·dependently increased their total amount of TF; no substantive differences in the Ieveis of 
enhanced TF expression were observed between WKY and SHR BMECs. We conclude that stimulated endothelium from rats with hypertension, 
a major stroke risk factor, is not hyperresponsive with respect to TF expression when compared to normotensive controls. 
We have previously reported that rats with risk 
factors for stroke such as hypertension, advanced age 
and diabetes, develop mare strake events than contral 
rats when the animals are challenged with a single dose 
of lipopolysaccharide (LPS) 10• Differences in response 
to a provocative dose of LPS in vivo between rats with 
and without risk factors for strake may depend an the 
degree of prothrambotic transfarmation which ulti-
mately occurs in lacal endothelium4 - 6• This local trans-
farmation could be pramoted by the risk factor indi-
rectly through accumulation of perivascular macro-
phages that release cytokines such as tumor necrosis 
factor-a (TNF-a) and interleukin-1 (IL-1 ). These cy-
tokines render endothelium procoagulant4•5•7 and in-
crease cellular adhesion26• Another possibility is that 
the sensitivity to different endothelial cell (EC) activa-
tors of hemostasis such as IL·l, TNF-a and LPS has 
been enhanced by the risk factor acting directly on the 
endothelium. lt would be consistent with the latter 
possibility if the response of brain EC from hyperten-
sivt; rats to LPS, IL·l and TNF-a were to be an 
enhanced expression of tissue factor (TF) compared to 
that of brain ECs from normotensive rats. 
TF is a SO kDa phospholipid-protein complex that 
triggers blood coagulation in association with factor 
VII via the extrinsic pathway 22• lt is known to be 
constitutively synthesized by a variety of cells including 
fibroblasts 15•16, macrophages2•23, smooth muscle 
cells15•16 and EC6•14•16•21 • In addition, numerous studies 
have shown that LPS6•14.21, TNF-a3•7•24, and IL-13.2s, 
increase TF synthesis and expression in a variety of 
cells in culture. 
In the present paper, we tested the hypothesis that 
the differences in stroke events between normotensive 
and hypertensive rats obseiVed after LPS treatment in 
vivo 11 may in part be due to differences (as a result of 
the hypertension) in the reactivity of their brain ECs to 
prothrombotic mediators such as LPS, IL-1 and TNF-a. 
Therefore, we have compared the effects of these 
factors on TF expression by brain microvascular EC 
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(BMEC) isolated from WKY (normotensive) and SHR 
(hypertensive). 
BMEC were isolated following the procedures de-
scribed by Williams et al.27 with some modifications9• 
Foreach preparation, five (16-22-week-old) WKY and 
SHR rats were utilized and isolated BMECs were 
plated in 24-well tissue culture plates precoated with 
Matrigel (Collaborative Research, Bedford, MA) and 
incubated at 37°C in a humidified, 5% co2 atmos· 
phere; media was changed after 24 h and then every 3 
days. The viability of the cells was tested at the end of 
the preparation by a Trypan blue exclusion technique 1• 
Cultures were characterized by staining with antiborlies 
to the endothelial cell-specific marker, von Willebrand 
(FVIII-related) antigen and the astrocyte-specific 
marker glial fibrillacy acidic protein (GFAP), and ex-
amined by indirect immunofluorescence microscopy as 
previously described18• Cell numbers in cultures were 
quantitated by a fluorometric assay as previously de-
scribed17. The Hoechst 33258 (Hoefer Scientific Instru-
ments; San Francisco, CA) was used as a fluorescent 
probe, and fluorescence was measured in a Perkin 
Eimer LS-5 tluorescence spectrophotometer set to 365 
nM excitation and 458 nM emission. ·The measured 
amount of total DNA was then converted to cell num-
bers by assuming 6 pg DNAjcell13• It was noted that 
Matrigel, when fresh, contains DNA but the DNA 
becomes hydrolyzed and disappears during the initial 
24-48 h of plating. 
Experiments were performed 10-18 days after the 
initial preparation. After this time, the media was 
removed, and 1 ml of either the same media (control) 
or LPS (0.01, 1 or 100 p.gfml} (E. coli 011 1:84; 
Sigma), thrombin (1 or 10 U/ml), A23187 (10 ,.,.M), 
PMA (100 nM), or TNF (5 Ujml} and IL-1 (20 U/mO 
was introduced. Jncubation was carried out for 30 min, 
1 h, 4 h, or 8 h at 3rC in a humidified atmosphere in 
S% 002• After the experiment, the cells were gently 
washed twice with Trisfsaline buffer, and the plates 
were frozen at - 80°C. 
Tissue factor activity was estimated by a two-stage 
amidolytic assay using purified factors -X and VII 
(Sigma) as previously described 15.25. Briefly, BMEC 
were submitted 3 times to a freeze and thaw cycle and 
were pipetted (100 p.!) into plastic tubes and placed in 
a water bath at 3'rC. TF activity was assessed by 
incubation (37°C, 5 min) with 200 ,.,.1 mixture of factor 
X (300 nM) and factor VII (0.5 nM) in 20 mM Tris (pH 
7.4), 135 mM NaCI, and 0.5% BSA followed by addi-
tion of 100 ,.,.1 of 2S mM Caa2• Factor Xa amidolytic 
activity was assessed by monitaring the hydrolysis (in-
crease in absorbance at 405 nm) of the synthetic pep-
tide ßz.ne-Giu-Arg·p-nitronilide (S-2222, KabiVitrum). 
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Under these conditions, factor Xa formation was linear 
and limited only by the amount of TF present. TF 
concentration was determined from a standard curve 
created by serial dilutions of rabbit brain TF (Sigma). 
A one-stage clotting (plasma recalcification) assay 
using either pooled normal plasma (PNP) or factor 
VII-deficient plasma (George King Bio.Medical, Over-
land Park, KS) was performed as previously de-
scnbed4·14. Similar assays were performed using rabbit 
brain TF (Sigma) and rat brain TF (saline extract of rat 
brain homogenate12 ) incubated with indicated concen-
trations of phospholipase-C (PHL-C; Sigma) or Con-A 
(30 min, 37°C), which inhibit TF procoagulant 
activity2·8•14. The time to form a clot was moniiored 
with a Fibrometer; one unit of TF was defined as the 
amount of TF required to generate a thromboplastin 
time equal to 40 s. 
The final BMEC preparation consisted of small 
groups of cells in the form of microvessel fragments 
and some single EC. In recent experiments, we have 
demonstrated by means of total DNA per weH quan-
tific.ation, that approximately 104 cells were seeded per 
weil and that our plating method permits homogeneaus 
plating with no significant difference in the amount of 
DNA between wells. Viability of the cells was consis-
tently more than 80% as assayed on an intermittent 
basis by the Trypan blue exclusion method. Analysis of 
BMEC cultures by indirect immunofluorescence mi-
croscopy revealed that > 95% of cultured cells were 
routinely positive for FVIII-related antigen and < 2% 
stained positively for OFAP. 
The one-stage clotting times of factor VII-deficient 
plasma and PNP in the presence of different serially 
diluted concentrations of rat TF were compared. Clot-
ting times generated by TF (1 and 0.1 ~gj.ml) mixed 
with factor Vll-deficient plasma were much Ionger (10 
s and 135 s, respectively) than those mixed with PNP 
(40 s and llS :;, respectively). The same dependence on 
fa~;tor VII was found with the amidolytic assay, where 
almost no TF activity was observed when rat TF was 
tested with only factor X (0.0.405 nm = 0.090) as op-
posed to factors X and VII (0.0.405 nm = 0.725). More-
over, PHL-C (10-100 p.gjml} and Con A (40-200 
~-tgfml} dose-dependently inhibited both rabbit and rat 
TF procoagulant activity in the one-stage clotting assay 
(results not shown). 
When BMEC from WKY and SHR were incubated 
for 8 h with different doses of LPS, both WKY and 
SHR BMEC dose-dependently increased their total 
amount of TF (Fig. 1). This effect reached significance 
at 1 IJ.8/ml and 100 p.gjml (P < 0.01). However, there 
were no significant differences in the amount of TF 
expressed by WKY and SHR BMECs. Treatment with 
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100 1'1/ml LPS for 1 h and 4 h also resulted in lesser 
though significant Ievels of TF release from both SHR 
and WKY EC; no reproducibly significant differences 
were observed between SHR or WKY BMECs. 
The ability of factors other than LPS to enhance 
expression was also examined. As shown in Table I, 
treatment with TNF + IL-1 or thrombin caused signifi· 
cant TF expression by both SHR and WKY BMECs 
( P < 0.05). In additional experiments not reported here, 
treatrnent with A23187, PMA, and higher concentra· 
tions of thrombin (i.e. 10 U jml) also resulted in en-
hanced TF expression above background in all BMEC 
cultures. In the data shown in Table I, as weil as the 
data obtained from additional experiments described 
abovc, no significant differences were obseJVed be· 
tween SHR and WKY BMEC cultures. 
We show that BMEC from normotensive and hyper· 
tensive rats express dose-dependent increments of TF 
when the cells are stimu~ated with LPS (Fig. 1), throm-
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Fig. I. Comparison of TF activity present on BMECs from WHY and 
SHR rals afler LPS treatment. BMECs from WKY and SHR rats 
were isolated and plated onto Matrigel as described before. After 14 
days, the cells were incubated wlth I ml of different doses of LPS 
dilured in M 199, 2 mM glutamine. lncubation was for 8 h at J'r'C in 
a humidified incubator after which the plates we"e placed at J'r'C in 
u water bath, and washed 3 times with Tris/saline buffer. After the 
last wash. the buffer was removed and cells were subjected to 3 
freeze and thaw cycles, followed by the amidolytic assay as described 
in Materials und Methods. The data werc interpolated from a 
standard curve prepared by serial dilutions of Sigma TF. One unit is 
defined as the amount of TF necessary to form a clot in 40 s in the 
one-stage clott~lg assay (n = 6; • = P < 0.01). The data have been 
standardized by measuring the amount of DNA in each weil and 
as.~uming a DNA concentration equal to 6 p.gfcell13• 
'fABLE I 
Elfecis of TNF + IL·l or thrombin on TF expression by SHR and WKY 
BMEC 
Treatment a TF Expression b 
SHR WKY 
lh 
0 0.056 ± 0.004 0.059 ± 0.005 
TNF+ IL-1 0.072±0.001 0.074 ± 0.004 
Thrombin 0.072± 0.007 0.092 ± 0.013 
4h 
0 0.078± 0.004 0.084 ± 0.008 
TNF+IL-1 0.101 ± 0.009 0.096± 0.005 
Thrombin 0.211 ±0.011 0.297 ± 0.017 
° Cells were treated for indicated time periods with 'l'NF (5 U jml) 
+IL-1 (20 U/ml> or thrombin (1 U/mO. 
b Data for TF expression are presented on 0.0.405 nm ± S.E.M. 
obtained from amidolytic assay as described in Materials and 
Methods. 
bin and the combination of TNF + IL-1 (Table I) as 
weil as PMA and A23187 (results not shown). In all 
experiments, no significant differences in Ievels of TF 
expression were observed between the two groups. 
Validation of the techniques used to measure TF pro-
coagulant activity from rat vessels consisted of a greatly 
reduced procoagulant effect in factor VII-deficient 
plasma, and inactivation of rat TF preparation by 
PHL-C 2•14 and Con·A8• 
We have postulated that risk factors for stroke could 
create an environment in which the probability of an 
Interaction between perivascular monocytes and 
macrophages with endothelium via cytokines such as 
TNF-a and IL·l is increaseduua. This interaction could 
increase the probability of local thrombosis or hemor· 
rhage in focal regions of the brain circulatory system 
and is viewed as equivalent to the preparatory step in 
the local Shwartzman reaction paradigm19• Such an 
interaction could be intensified by increasing the num-
ber of perivascular monocytes and macrophages in 
extracranial and intracranial vessels andjor rendering 
these cells hyperresponsive. Conversely, the endothe-
lium lining blood vessels of the brain in animals with 
risk factors for stroke could be hyperresponsive and 
express more TF after appropriate stimulation than 
animals devoid of such risk factors. We have observed 
that SHR produce more TNF-a in blood and cere-
braspinal fluid in response to LPS than their nor-
motensive progenitor, WKY 11 • This suggests that hy-
pertension may be associated with activation of the 
monocyte I macrophage arm of the postulated interac-
tion. The present study has explored whetber the EC 
of hypertensive animals is similarly activ~ted, and thc 
data suggest that for induction of TF by LPS and other 
factors used in these experiments, it is not. This finding 
does not, however, exclude the possibility that stroke 
risk factors are associated with other forms of EC 
activation, such as adhesion receptor expression or that 
in vivo stimulation with factors utilized here might 
produce differential TF expression by EC in the two 
groups of animals. 
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